OraSure’s DNA Genotek subsidiary received FDA EUA for its ORAcollect-RNA saliva collectiondevice for SARS CoV-2
On Nov. 3, 2020, OraSure Technologies announced its DNA Genotek subsidiary has received Emergency Use Authorization from the (FDA for the use of the ORAcollect-RNA (OR/ORE-100) saliva collection device for the collection, stabilization and transport of saliva specimens suspected of containing SARS-CoV-2 RNA.
This is the second FDA EUA that DNA Genotek has received for its saliva collection devices.
Tags:
Source: OraSure Technologies
Credit: